(Q34291361)

English

The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Stickler M

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Valdes AM

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gebel W

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Razo OJ

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Faravashi N

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Chin R

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Rochanayon N

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Harding FA

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Genes and Immunity

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1-7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

Immunoglobulin class switching

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

CD4+ T-cell epitope determination using unexposed human donor peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

Genetics of multiple sclerosis: linkage and association studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

The combination of HLA-DR1 and HLA-DR53 protects against MS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

Immunoglobulin Subclasses in Patients with Neutralizing and Nonneutralizing Antibodies Against IFN-β1b

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

21 January 2018

Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulatory effects of interferon beta-1a in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism and regulation of immunoglobulin isotype switching.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-DR15 and age at onset in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

7 January 2021

based on heuristic

inferred from DOI database lookup

Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-pin peptide synthesis strategy for T cell determinant analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364027

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GENE.6364027

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34291361&oldid=2196468256"